Hidradenitis Suppurativa Market to Showcase Remarkable Growth at a CAGR of 12.4 percent by 2034 DelveInsight
| RYCFX Fund | USD 42.49 0.25 0.58% |
Slightly above 62% of Biotechnology Fund's investor base is looking to short. The analysis of overall sentiment of trading Biotechnology Fund Class mutual fund suggests that many investors are alarmed at this time. Biotechnology Fund's investing sentiment can be driven by a variety of factors including economic data, Biotechnology Fund's earnings reports, geopolitical events, and overall market trends.
Biotechnology |
According to DelveInsights analysis, the growth of the hidradenitis suppurativa market is expected to be mainly driven by the rise in awareness and access to treatment, recent approval of biologic therapies, anticipated approval of JAK-inhibitors nanobodies and robust pipeline activity in the 7MM.New York, USA, Nov. 20, 2024 -- Hidradenitis Suppurativa Market to Showcase Remarkable Growth at a CAGR of 12.4 percent by 2034 DelveInsight According to DelveInsights analysis, the grow
Read at finance.yahoo.com
 |
Biotechnology Fund Fundamental Analysis
We analyze Biotechnology Fund's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotechnology Fund using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotechnology Fund based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Biotechnology Fund is currently under evaluation in number of employees among similar funds. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Biotechnology Fund Class Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biotechnology Fund mutual fund to make a market-neutral strategy. Peer analysis of Biotechnology Fund could also be used in its relative valuation, which is a method of valuing Biotechnology Fund by comparing valuation metrics with similar companies.
Peers
Biotechnology Fund Related Equities
| HIIDX | Harbor Diversified | 0.40 | ||||
| MNDWX | Manning Napier | 0.38 | ||||
| DLTZX | Delaware Limited-term | 0.13 | ||||
| GPICX | Guidepath Conservative | 0.10 | ||||
| VYRPX | Voya Solution | 0.1 | ||||
| QDARX | Aqr Diversified | 0.08 | ||||
| SRDAX | Stone Ridge | 0.09 | ||||
| JDJRX | Jhancock Diversified | 0.11 |
Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Fund financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Fund security.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |